• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒在希腊急性非甲非乙型肝炎中的作用:一项为期5年的前瞻性研究。

Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study.

作者信息

Tassopoulos N C, Hatzakis A, Delladetsima I, Koutelou M G, Todoulos A, Miriagou V

机构信息

First Department of Medicine, Western Attica General Hospital, Athens, Greece.

出版信息

Gastroenterology. 1992 Mar;102(3):969-72. doi: 10.1016/0016-5085(92)90184-z.

DOI:10.1016/0016-5085(92)90184-z
PMID:1311275
Abstract

The prevalence of hepatitis C virus (HCV) infection in 182 prospectively followed adult patients (110 males, 72 females) with acute non-A, non-B hepatitis and its correlation with progression to chronic hepatitis were studied. These patients were followed for a mean of 24.7 +/- 13.1 (range, 6-57) months. By using a specific enzyme immunoassay for the detection of antibodies against C100-3 polypeptide of HCV, 96 (52.7%) were found antibody positive. HCV was implicated in 64/89 (71.9%) of the cases with classical parenteral exposure but only in 18/64 (28.1%) of the community-acquired cases. Progression to chronic hepatitis was observed more frequently in antibody-positive than in antibody-negative cases (60/96 or 62.5% vs. 27/86 or 31.4%, P = 0.00002). Progression was also observed more often in males than in females (66/112 or 58.9% vs. 21/70 or 30.0% P = 0.0001), both in the antibody positive (48/68 or 70.6% vs. 12/28 or 42.9%, P = 0.01) and in the antibody negative (18/44 or 40.9% vs. 9/42 or 21.4%, P = 0.043) cases. These data indicate that (a) acute hepatitis due to HCV is characterized by a high rate of chronicity, especially in males, and (b) a non-A, non-B, non-C agent or a different strain of HCV may be responsible for the majority of the community-acquired cases of non-A, non-B hepatitis in Greece.

摘要

对182例前瞻性随访的急性非甲非乙型肝炎成年患者(110例男性,72例女性)进行丙型肝炎病毒(HCV)感染率及其与慢性肝炎进展相关性的研究。这些患者平均随访了24.7±13.1(范围6 - 57)个月。通过使用检测抗HCV C100 - 3多肽抗体的特异性酶免疫测定法,发现96例(52.7%)抗体呈阳性。在有典型肠道外暴露史的89例病例中,64例(71.9%)与HCV有关,但社区获得性病例中仅18例(28.1%)与HCV有关。抗体阳性病例比抗体阴性病例更常进展为慢性肝炎(60/96或62.5% 对27/86或31.4%,P = 0.00002)。男性比女性更常出现进展(66/112或58.9% 对21/70或30.0%,P = 0.0001),抗体阳性病例(48/68或70.6% 对12/28或42.9%,P = 0.01)和抗体阴性病例(18/44或40.9% 对9/42或21.4%,P = 0.043)均如此。这些数据表明:(a)由HCV引起的急性肝炎的特点是慢性化率高,尤其是在男性中;(b)在希腊,非甲非乙型肝炎的社区获得性病例多数可能由非甲非乙非丙型病原体或不同株的HCV引起。

相似文献

1
Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study.丙型肝炎病毒在希腊急性非甲非乙型肝炎中的作用:一项为期5年的前瞻性研究。
Gastroenterology. 1992 Mar;102(3):969-72. doi: 10.1016/0016-5085(92)90184-z.
2
Prevalence of antibody to hepatitis C virus in prospectively followed acute non-A, non-B hepatitis, from different epidemiological categories.来自不同流行病学类别的前瞻性随访急性非甲非乙型肝炎患者中丙型肝炎病毒抗体的流行情况。
Liver. 1991 Jun;11(3):129-33. doi: 10.1111/j.1600-0676.1991.tb00505.x.
3
Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.伦敦非甲非乙型输血后肝炎的低发病率经丙型肝炎病毒血清学证实。
Lancet. 1991 Mar 30;337(8744):753-7. doi: 10.1016/0140-6736(91)91370-a.
4
A prospective study of posttransfusion hepatitis in Taiwan.台湾地区输血后肝炎的前瞻性研究。
J Hepatol. 1991 Jul;13(1):38-43. doi: 10.1016/0168-8278(91)90861-5.
5
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.美国社区获得性丙型肝炎的自然史。哨兵县慢性非甲非乙型肝炎研究小组。
N Engl J Med. 1992 Dec 31;327(27):1899-905. doi: 10.1056/NEJM199212313272702.
6
Antibody to hepatitis C virus in post-transfusion hepatitis.输血后肝炎中的丙型肝炎病毒抗体。
Ann Intern Med. 1991 Feb 15;114(4):277-81. doi: 10.7326/0003-4819-114-4-277.
7
Patterns and prevalence of hepatitis C virus infection in posttransfusion non-A, non-B hepatitis.输血后非甲非乙型肝炎中丙型肝炎病毒感染的模式与流行率
J Infect Dis. 1993 Jun;167(6):1296-301. doi: 10.1093/infdis/167.6.1296.
8
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.前瞻性随访的急性和慢性非甲非乙型肝炎输血受者中丙型肝炎病毒抗体的检测
N Engl J Med. 1989 Nov 30;321(22):1494-500. doi: 10.1056/NEJM198911303212202.
9
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.普通人群丙型肝炎病毒感染的患病率、危险因素及基因型分布:意大利南部一项基于社区的调查
Hepatology. 1997 Oct;26(4):1006-11. doi: 10.1002/hep.510260431.
10
Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.在一项输血相关性肝炎研究中对丙型肝炎病毒抗体的评估。
N Engl J Med. 1990 Oct 18;323(16):1107-12. doi: 10.1056/NEJM199010183231605.

引用本文的文献

1
Hepatitis G virus: is it a hepatitis virus?庚型肝炎病毒:它是一种肝炎病毒吗?
West J Med. 1997 Jul;167(1):23-33.
2
Patterns of progression: unpredictability and risk of decompensated cirrhosis.
Dig Dis Sci. 1996 Dec;41(12 Suppl):41S-48S. doi: 10.1007/BF02087875.
3
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor.丙型肝炎病毒核心蛋白与淋巴毒素-β受体的胞质尾相互作用。
J Virol. 1997 Feb;71(2):1301-9. doi: 10.1128/JVI.71.2.1301-1309.1997.
4
Interferon as treatment for acute hepatitis C. A meta-analysis.干扰素治疗急性丙型肝炎。一项荟萃分析。
Dig Dis Sci. 1996 Jun;41(6):1248-55. doi: 10.1007/BF02088245.
5
Acute non-A, non-B hepatitis in Italy: a 16-year prospective epidemiological study. The possible role of hepatitis C virus.意大利急性非甲非乙型肝炎:一项为期16年的前瞻性流行病学研究。丙型肝炎病毒的潜在作用。
Infection. 1994 Sep-Oct;22(5):321-5. doi: 10.1007/BF01715537.
6
Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.重组人干扰素α-2b治疗急性非甲非乙型肝炎
Gut. 1993;34(2 Suppl):S130-2. doi: 10.1136/gut.34.2_suppl.s130.
7
Epidemiological, clinical and biological characteristics of acute non-A, non-B hepatitis with and without hepatitis C virus infection.伴有和不伴有丙型肝炎病毒感染的急性非甲非乙型肝炎的流行病学、临床及生物学特征
Infection. 1994 Jul-Aug;22(4):252-7. doi: 10.1007/BF01739909.
8
Treatment of acute non-A, non-B hepatitis with interferon alpha-2b.用α-2b干扰素治疗急性非甲非乙型肝炎。
Infection. 1992 Jul-Aug;20(4):242. doi: 10.1007/BF02033074.